Nodica Group is mainly owned by the investment company Bure Growth AB and two venture capital investors, Stiftelsen Industrifonden and SEB Venture Capital. The remaining shares are distributed between private owners and employees.
Bure is an investment company based in Stockholm and has been listed on Nasdaq Stockholm since 1993. By actively developing a diversified portfolio of professionally managed companies and businesses, Bure aims to create value and returns for its shareholders. Bure’s investments currently consist of twelve portfolio companies, most of which are technology-based with a strong focus on international markets.
Industrifonden is an independent foundation managing approximately SEK 5 billion, investing in early-stage and growth-stage companies within deep tech, life sciences, and transformative technology. Initial investments typically range from SEK 10–50 million, with the capacity for additional reinvestments during the holding period. With 40 years of experience in scaling and growth, Industrifonden’s investment portfolio includes companies such as Funnel, EnginZyme, Asgard Therapeutics, Arcam, Oatly, and CellaVision. Industrifonden is constantly seeking transformative investment opportunities in Sweden — those with the potential to drive meaningful improvements in people’s lives, industries, and society.
SEB Venture is a unit within SEB, operating in the Venture Capital segment since 1995. Since its inception, over 100 investments have been made, primarily in B2B technology and life sciences. However, since the late 2010s, SEB Venture has primarily focused on FinTech investments.
Customers
Countries
Employees globally
Years of expertise